培米替尼在国内哪里可以买到？培米替尼购买途径

It is a selective FGFR tyrosine kinase inhibitor jointly developed by Innovent Biologics and Incyte. It was approved by the U.S. Food and Drug Administration (FDA) under the accelerated approval process on April 17, 2020, for the treatment of locally advanced or metastatic cholangiocarcinoma with FGFR2 fusion or rearrangement.

培米替尼是一种FGFR1-3的小分子酪氨酸激酶抑制剂,在体外能抑制FGFR4,其抑制浓度约为FGFR1-3的100倍。在FGFR2融合或重排的胆管癌患者中,FGFR信号的组成性激活可以支持恶性肿瘤细胞的增殖和生存。 Pemetinib selectively inhibits the growth of tumor cells by inhibiting FGFR1-3 phosphorylation and signaling processes, blocking the constitutive activation of FGFR signaling caused by FGFR amplification and fusion. Preclinical studies have shown that pemetinib shows good anti-tumor activity against FGFR1~3 mutated tumor cells in cell line models and mouse human tumor xenograft models.

Where can I buy pemetinib in China? Where to buy pemetinib? Pemetinib is an unmarketed drug in China. Because the drug is not on the market, it is not available in China. The price of pemetinib abroad is very expensive, not to mention the cost of traveling abroad. Most patients think that the only way to purchase pemetinib is to purchase the drug overseas, but this method is more expensive and requires a long round trip, which puts a considerable burden on the patient's family. At this time, patients can choose the domestic and overseas medical service organization Medical Companion Travel to help them purchase drugs overseas. The price of pemetinib purchased by Medical Companion Travel is more affordable, and the drug purchase method is safe. Overseas direct mail, the medicine is delivered directly to the patient, and is 100% authentic. For details, please contact Medical Companion Travel to answer your questions.

Note: The above information comes from the Internet and is compiled and edited by Medical Companion Travel (please correct me if there are any errors or omissions). It is only to provide information on the latest drugs on the market in the world and help Chinese patients understand the latest international new drug trends. It is only for internal discussion among medical staff and does not serve as any basis for medication. For specific medication guidelines, please consult the attending physician.